Insider Transactions in Q4 2024 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 29
2024
|
Alexander Hardy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,295
-9.63%
|
$943,470
$66.03 P/Share
|
|
Nov 12
2024
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
5,278
-7.11%
|
$348,348
$66.37 P/Share
|
|
Oct 31
2024
|
Alexander Hardy Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300
+0.2%
|
$16,800
$56.01 P/Share
|
|
Oct 31
2024
|
Charles Greg Guyer EVP, Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55
+0.07%
|
$3,080
$56.01 P/Share
|